相关实验视频

Updated: May 13, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

血清神经丝光链作为多发性硬化症生物标志物的实际用途

Jada Coker¹, Anisha Doshi², Sharmilee Gnanapavan³

¹Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, PE30 4ET, United Kingdom.

Multiple sclerosis and related disorders

|June 5, 2025

概括

血清神经纤维光链 (sNfL) 是多发性硬化症 (MS) 中神经轴突损伤的有希望的生物标志物. 了解其用途和局限性对于诊断和监测MS的临床应用至关重要.

科学领域:

神经科学是一个神经科学.
生物标志物发现发现
临床神经学临床神经学

背景情况:

神经纤维光链 (NfL) 是神经元轴突的一个关键组成部分.
血清NfL (sNfL) 升高表明神经轴损伤.
sNfL是神经系统疾病的公认生物标志物,包括多发性硬化症 (MS).

研究的目的:

阐明sNfL在MS中的诊断,预后,预测和监测作用.
评估sNfL在指导MS治疗决策中的有用性.
确定影响sNfL可靠性的因素,并提出缓解策略.

主要方法:

对MS中sNfL的当前文献的审查和综合.
在不同临床应用中评估sNfL作为生物标志物.
分析影响sNfL测量和解释的因素.

主要成果:

sNfL显示出作为诊断,预测和监测MS的生物标志物的潜力.
sNfL可能有助于治疗选择和反应评估.
几个因素会影响sNfL的可靠性,需要仔细考虑.

结论:

sNfL是管理多发性硬化症的宝贵工具,但其临床实施需要了解其局限性.
需要进一步的研究来优化sNfL在临床实践中的使用.
确保sNfL可靠性的策略对于其有效应用至关重要.

关键词:

生物标志物生物标志物改变疾病的治疗方法.多发性硬化症是多发性硬化症.神经纤维光电链的链条

更多相关视频

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

相关概念视频

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...